Literature DB >> 9788446

A KRAB-related domain and a novel transcription repression domain in proteins encoded by SSX genes that are disrupted in human sarcomas.

F L Lim1, M Soulez, D Koczan, H J Thiesen, J C Knight.   

Abstract

SSX genes show extensive nucleotide sequence conservation but little is known of their function. Disruption of SSX1 or SSX2, by chromosome translocation and 'in-frame' fusion to SYT, is a consistent feature of synovial sarcomas. The resulting SYT-SSX1/SSX2 proteins are activators of transcription; transactivation function is located in SYT. Unrearranged SSX1 can repress transcription, and this has been attributed to a putative Krüppel associated box (KRAB) repression domain at the N-terminus. Here we isolated SSX-KRAB domains to specifically measure repression activity, using a previously characterized KOX1-KRAB domain as a control. In our repressor assay SSX1- and SSX2-KRAB domains down-modulated the transactivation of a reporter gene by threefold, compared with 83-fold repression achieved by KOX1-KRAB in the assay. Yeast two-hybrid analysis showed that SSX1-KRAB, unlike KOX1-KRAB, fails to interact with the KRAB co-repressor TIF1beta. These results raise questions about the evolutionary and functional relationship of SSX-KRAB and typical KRAB domains of Krüppel zinc finger genes. We found that full-length SSX1 showed potent (74-fold) repression in our repressor assay, indicating the existence of a repression domain distinct from SSX-KRAB. By assaying deletion constructs of SSX1 we localized repression activity to 33 amino acids at the C-terminus. This novel domain is conserved between SSX family members, and, unlike the KRAB-related domain, is retained on fusion with SYT. This has important implications in understanding the mechanism by which the SYT-SSX fusion protein could contribute to neoplasia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9788446     DOI: 10.1038/sj.onc.1202122

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  40 in total

1.  Ectopic expression of cancer/testis antigen SSX2 induces DNA damage and promotes genomic instability.

Authors:  Katrine B V Greve; Jonas N Lindgreen; Mikkel G Terp; Christina B Pedersen; Steffen Schmidt; Jan Mollenhauer; Stine B Kristensen; Rikke S Andersen; Mette M Relster; Henrik J Ditzel; Morten F Gjerstorff
Journal:  Mol Oncol       Date:  2014-10-06       Impact factor: 6.603

2.  Analysis of transforming activity of human synovial sarcoma-associated chimeric protein SYT-SSX1 bound to chromatin remodeling factor hBRM/hSNF2 alpha.

Authors:  M Nagai; S Tanaka; M Tsuda; S Endo; H Kato; H Sonobe; A Minami; H Hiraga; H Nishihara; H Sawa; K Nagashima
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

Review 3.  Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy.

Authors:  Pierre G Coulie; Benoît J Van den Eynde; Pierre van der Bruggen; Thierry Boon
Journal:  Nat Rev Cancer       Date:  2014-02       Impact factor: 60.716

4.  The ancient mammalian KRAB zinc finger gene cluster on human chromosome 8q24.3 illustrates principles of C2H2 zinc finger evolution associated with unique expression profiles in human tissues.

Authors:  Peter Lorenz; Sabine Dietmann; Thomas Wilhelm; Dirk Koczan; Sandra Autran; Sophie Gad; Gaiping Wen; Guohui Ding; Yixue Li; Marie-Françoise Rousseau-Merck; Hans-Juergen Thiesen
Journal:  BMC Genomics       Date:  2010-03-26       Impact factor: 3.969

5.  Subnuclear distribution of SSX regulates its function.

Authors:  Jiaochen Wang; Huali Wang; Wei Hou; Haijing Liu; Yongxin Zou; Hong Zhang; Lin Hou; Michael A McNutt; Bo Zhang
Journal:  Mol Cell Biochem       Date:  2013-05-18       Impact factor: 3.396

6.  Deconstruction of the SS18-SSX fusion oncoprotein complex: insights into disease etiology and therapeutics.

Authors:  Le Su; Arthur V Sampaio; Kevin B Jones; Marina Pacheco; Angela Goytain; Shujun Lin; Neal Poulin; Lin Yi; Fabio M Rossi; Juergen Kast; Mario R Capecchi; T Michael Underhill; Torsten O Nielsen
Journal:  Cancer Cell       Date:  2012-03-20       Impact factor: 31.743

7.  Identification and functional characterization of glioma-specific promoters and their application in suicide gene therapy.

Authors:  Toshio Yawata; Yusuke Maeda; Makiko Okiku; Eri Ishida; Kazuhiro Ikenaka; Keiji Shimizu
Journal:  J Neurooncol       Date:  2011-02-24       Impact factor: 4.130

Review 8.  Synovial sarcoma: from genetics to genetic-based animal modeling.

Authors:  Malay Haldar; R Lor Randall; Mario R Capecchi
Journal:  Clin Orthop Relat Res       Date:  2008-06-18       Impact factor: 4.176

Review 9.  The SSX family of cancer-testis antigens as target proteins for tumor therapy.

Authors:  Heath A Smith; Douglas G McNeel
Journal:  Clin Dev Immunol       Date:  2010-10-11

10.  Epigenetic features of human mesenchymal stem cells determine their permissiveness for induction of relevant transcriptional changes by SYT-SSX1.

Authors:  Luisa Cironi; Paolo Provero; Nicola Riggi; Michalina Janiszewska; Domizio Suva; Mario-Luca Suva; Vincent Kindler; Ivan Stamenkovic
Journal:  PLoS One       Date:  2009-11-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.